Cystic Fibrosis Transmembrane Conductance Regulator Modulator Use Is Associated With Reduced Pancreatitis Hospitalizations in Patients With Cystic Fibrosis

The effect of CFTR modulators on a cystic fibrosis patient presenting with recurrent pancreatitis in the absence of respiratory symptoms: a case report

(2019) J. Dixon Johns et al.   BMC GASTROENTEROLOGY

Pancreatic insufficiency converted to pancreatic sufficiency with ivacaftor

(2019) Jennifer L. Hamilton et al.   PEDIATRIC PULMONOLOGY

Acute Recurrent and Chronic Pancreatitis as Initial Manifestations of Cystic Fibrosis and Cystic Fibrosis Transmembrane Conductance Regulator–Related Disorders

(2019) Christina Baldwin et al.   PANCREAS

Cystic fibrosis transmembrane conductance regulator modulators reduce the risk of recurrent acute pancreatitis among adult patients with pancreas sufficient cystic fibrosis

(2019) Venkata S. Akshintala et al.   PANCREATOLOGY

Cystic fibrosis carriers are at increased risk for a wide range of cystic fibrosis-related conditions

(2019) Aaron C. Miller et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Ivacaftor CFTR Potentiator Therapy is Efficient for Pancreatic Manifestations in Cystic Fibrosis

(2018) Ilias Kounis et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Effects of Lumacaftor–Ivacaftor Therapy on Cystic Fibrosis Transmembrane Conductance Regulator Function in Phe508del Homozygous Patients with Cystic Fibrosis

(2018) Simon Y. Graeber et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Reduction of Recurrence Risk of Pancreatitis in Cystic Fibrosis With Ivacaftor

(2018) Andres Carrion et al.   JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION

Healthcare expenditures for privately insured US patients with cystic fibrosis, 2010-2016

(2018) Scott D. Grosse et al.   PEDIATRIC PULMONOLOGY

Cystic Fibrosis of the Pancreas: The Role of CFTR Channel in the Regulation of Intracellular Ca2+ Signaling and Mitochondrial Function in the Exocrine Pancreas

(2018) Tamara Madácsy et al.   Frontiers in Physiology

Triplet CFTR modulators: future prospects for treatment of cystic fibrosis

(2018) Nauman Chaudary   Therapeutics and Clinical Risk Management

Tezacaftor–Ivacaftor in Residual-Function Heterozygotes with Cystic Fibrosis

(2017) Steven M. Rowe et al.   NEW ENGLAND JOURNAL OF MEDICINE

Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del

(2017) Jennifer L. Taylor-Cousar et al.   NEW ENGLAND JOURNAL OF MEDICINE

Impact of CFTR Modulation on Intestinal pH, Motility and Clinical Outcomes in Patients With Cystic Fibrosis and the G551D Mutation

(2017) Daniel Gelfond et al.   Clinical and Translational Gastroenterology

Challenges and Updates in the Management of Exocrine Pancreatic Insufficiency

(2016) Phil A. Hart et al.   PANCREAS

Alcohol Disrupts Levels and Function of the Cystic Fibrosis Transmembrane Conductance Regulator to Promote Development of Pancreatitis

(2015) József Maléth et al.   GASTROENTEROLOGY

Pancreatic pathophysiology in cystic fibrosis

(2015) Katherine N Gibson-Corley et al.   JOURNAL OF PATHOLOGY

The Physiology and Pathophysiology of Pancreatic Ductal Secretion

(2015) Petra Pallagi et al.   PANCREAS

The Cystic Fibrosis of Exocrine Pancreas

(2013) M. Wilschanski et al.   Cold Spring Harbor Perspectives in Medicine

Personalized Medicine in Cystic Fibrosis

(2012) John P. Clancy et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations in pancreatitis

(2012) Chee Y. Ooi et al.   Journal of Cystic Fibrosis

Symptomatic Pancreatitis in Patients With Cystic Fibrosis

(2009) Ian Gooding et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY